These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 5234302

  • 21. Stainable blood platelet glycogen in various conditions.
    Hermanský F, Hrodek O, Matousová O, Cieslar P.
    Acta Univ Carol Med Monogr; 1972; 53():165-71. PubMed ID: 4598518
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N.
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract] [Full Text] [Related]

  • 24. Serum beta-2-microglobulin in disorders of myeloid proliferation.
    Norfolk DR, Child JA, Roberts BE, Forbes MA, Cooper EH.
    Acta Haematol; 1983; 69(6):361-8. PubMed ID: 6190339
    [Abstract] [Full Text] [Related]

  • 25. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H, Clemmensen I.
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serum vitamin B 12 and vitamin B 12 binding capacity in chronic myelogenous leukemia and other disorders.
    Rosner F, Schreiber ZA.
    Am J Med Sci; 1972 Jun; 263(6):473-80. PubMed ID: 4505888
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [On the existence of a myeloproliferative factor in patients with a myeloproliferative syndrome (author's transl)].
    Essers U, Nowak H.
    Blut; 1979 Aug; 39(2):107-15. PubMed ID: 289427
    [Abstract] [Full Text] [Related]

  • 34. [Cytoautoradiographic studies on immature cells in chronic myeloid leukemia and myelofibrosis].
    Mauri C, Quaglino D, Emilia G, Zanni G, De Pasquale A.
    Haematologica; 1972 Aug; 57(12):865-76. PubMed ID: 4219205
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differences in inducing activity for human bone marrow colonies in normal serum and serum from patients with leukemia.
    Mintz U, Sachs L.
    Blood; 1973 Sep; 42(3):331-9. PubMed ID: 4516521
    [No Abstract] [Full Text] [Related]

  • 38. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I, Kahn SB, Ross EM, Petkov G.
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.